Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Accumulated Expenses (2021 - 2026)

Champions Oncology (CSBR) has 5 years of Other Accumulated Expenses data on record, last reported at $97000.0 in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 35.76% year-over-year to $97000.0; the TTM value through Oct 2025 reached $97000.0, down 35.76%, while the annual FY2025 figure was $135000.0, 10.0% down from the prior year.
  • Other Accumulated Expenses reached $97000.0 in Q4 2025 per CSBR's latest filing, down from $116000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $154000.0 in Q1 2025 and bottomed at $15000.0 in Q3 2021.
  • Average Other Accumulated Expenses over 5 years is $116000.0, with a median of $143500.0 recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: surged 860.0% in 2023, then crashed 35.76% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $15000.0 in 2021, then surged by 853.33% to $143000.0 in 2022, then grew by 3.5% to $148000.0 in 2023, then grew by 2.03% to $151000.0 in 2024, then tumbled by 35.76% to $97000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $97000.0 in Q4 2025, $116000.0 in Q3 2025, and $135000.0 in Q2 2025.